Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer

Annals of Surgical Oncology

Volumn 18, Issue 10, 2011, Pages 2912-2918

  McCann, Christopher K ^a   Growdon, Whitfield B ^a   Munro, Elizabeth G ^a   Del Carmen, Marcela G ^a   Boruta, David M ^a   Schorge, John O ^a   Goodman, Annekathryn ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DISEASE FREE INTERVAL; FEMALE; GYNECOLOGIC SURGERY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORBIDITY; OVARY CANCER; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROGNOSIS; SPLENECTOMY; SURGICAL MORTALITY;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; CYSTADENOCARCINOMA, SEROUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SPLENECTOMY; SURVIVAL RATE;

EID: 80052693068     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1661-z     Document Type: Article

References (36)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 249 19474385 10.3322/caac.20006
2. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics CA Cancer J Clin. 58 71 96 18287387 10.3322/CA.2007.0010 (Pubitemid 351521864)
3. WE Winter 3rd GL Maxwell C Tian, et al. 2007 Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol. 25 3621 3627 17704411 10.1200/JCO.2006.10.2517 (Pubitemid 47372600)
4. CT Griffiths 1975 Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma Natl Cancer Inst Monogr. 42 101 104 1234624 1:STN:280:DyaE2s%2Fls1ejsQ%3D%3D
5. RE Bristow RS Tomacruz DK Armstrong EL Trimble FJ Montz 2002 Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol. 20 1248 1259 11870167 10.1200/JCO.20.5.1248 (Pubitemid 34177431)
6. SM Eisenkop RL Friedman HJ Wang 1998 Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study Gynecol Oncol. 69 103 108 9600815 10.1006/gyno.1998.4955 1:STN:280:DyaK1c3mtlajuw%3D%3D (Pubitemid 28246994)
7. DS Chi CC Franklin DA Levine, et al. 2004 Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol Oncol. 94 650 654 15350354 10.1016/j.ygyno.2004.01.029 (Pubitemid 39194456)
8. EL Eisenhauer NR Abu-Rustum Y Sonoda, et al. 2006 The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer Gynecol Oncol. 103 1083 1090 16890277 10.1016/j.ygyno.2006.06.028 (Pubitemid 44821338)
9. SM Kehoe EL Eisenhauer DS Chi 2008 Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy Gynecol Oncol. 111 S51 S55 18801559 10.1016/j.ygyno.2008. 07.053
10. G Glockzin HJ Schlitt P Piso 2009 Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy World J Surg Oncol. 7 5 19133112 10.1186/1477-7819-7-5
11. Meigs JV. Tumors of Female Pelvic Organs. New York: Macmillan Co; 1934.
12. T Le GV Krepart RJ Lotocki MS Heywood 1997 Does debulking surgery improve survival in biologically aggressive ovarian carcinoma? Gynecol Oncol. 67 208 214 9367710 10.1006/gyno.1997.4839 1:STN:280:DyaK1c%2FjsFymuw%3D%3D (Pubitemid 27500422)
13. AP Makar M Baekelandt CG Trope GB Kristensen 1995 The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer Gynecol Oncol. 56 175 180 7896181 10.1006/gyno.1995.1027 1:STN:280:DyaK2M3gtlOluw%3D%3D
14. AL Covens 2000 A critique of surgical cytoreduction in advanced ovarian cancer Gynecol Oncol. 78 269 274 10985879 10.1006/gyno.2000.5926 1:STN:280:DC%2BD3cvlsl2ltg%3D%3D
15. SM Eisenkop NM Spirtos 2001 What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol Oncol. 82 489 497 11520145 10.1006/gyno.2001.6312 1:STN:280:DC%2BD3Mvnslahug%3D%3D (Pubitemid 32826449)
16. SM Eisenkop NM Spirtos WC Lin 2006 Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer Gynecol Oncol. 100 344 348 16202446 10.1016/j.ygyno.2005.08.036 (Pubitemid 43075267)
17. PM Magtibay PB Adams MB Silverman SS Cha KC Podratz 2006 Splenectomy as part of cytoreductive surgery in ovarian cancer Gynecol Oncol. 102 369 374 16631919 10.1016/j.ygyno.2006.03.028 (Pubitemid 44041661)
18. LM Chen RS Leuchter LD Lagasse BY Karlan 2000 Splenectomy and surgical cytoreduction for ovarian cancer Gynecol Oncol. 77 362 368 10831343 10.1006/gyno.2000.5800 1:STN:280:DC%2BD3c3ptlSrsg%3D%3D (Pubitemid 30368551)
19. EW Sonnendecker F Guidozzi KA Margolius 1989 Splenectomy during primary maximal cytoreductive surgery for epithelial ovarian cancer Gynecol Oncol. 35 301 306 2599464 10.1016/0090-8258(89)90068-1 1:STN:280:DyaK3c%2FptlWhsQ%3D%3D (Pubitemid 20025891)
20. SM Kehoe EL Eisenhauer NR Abu-Rustum, et al. 2009 Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer Gynecol Oncol. 112 496 500 19091388 10.1016/j.ygyno.2008.10.011
21. JL Nicklin LJ Copeland RV O'Toole GS Lewandowski L Vaccarello LP Havenar 1995 Splenectomy as part of cytoreductive surgery for ovarian carcinoma Gynecol Oncol. 58 244 247 7622112 10.1006/gyno.1995.1218 1:STN:280:DyaK2MzkslKltw%3D%3D
22. JJ Bonenkamp J Hermans M Sasako, et al. 1999 Extended lymph-node dissection for gastric cancer N Engl J Med. 340 908 914 10089184 10.1056/NEJM199903253401202 1:STN:280:DyaK1M7ntlertQ%3D%3D (Pubitemid 29141051)
23. KY Lee SH Noh WJ Hyung, et al. 2001 Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer Ann Surg Oncol. 8 402 406 11407513 10.1007/s10434-001-0402-0
24. SP Monig PH Collet SE Baldus, et al. 2001 Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus J Surg Oncol. 76 89 92 11223832 10.1002/1096-9098(200102)76:2<89::AID-JSO1016>3.0.CO;2-I 1:STN:280:DC%2BD3M3hsV2isA%3D%3D (Pubitemid 32164633)
25. SJ Oh WJ Hyung C Li, et al. 2009 The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer J Surg Oncol. 99 275 280 19152367 10.1002/jso.21229
26. E Otsuji T Yamaguchi K Sawai M Ohara T Takahashi 1996 End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma Surgery. 120 40 44 8693421 10.1016/S0039-6060(96)80239-X 1:STN:280:DyaK28zgvFCjtA%3D%3D (Pubitemid 26275281)
27. Y Adachi T Kamakura M Mori Y Maehara K Sugimachi 1994 Role of lymph node dissection and splenectomy in node-positive gastric carcinoma Surgery. 116 837 841 7940186 1:STN:280:DyaK2M%2Fis1Cksw%3D%3D (Pubitemid 24347191)
28. K Yang XZ Chen JK Hu B Zhang ZX Chen JP Chen 2009 Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis World J Gastroenterol. 15 5352 5359 19908346 10.3748/wjg.15.5352
29. N Carrere S Abid CH Julio E Bloom B Pradere 2007 Spleen-preserving distal pancreatectomy with excision of splenic artery and vein: a case-matched comparison with conventional distal pancreatectomy with splenectomy World J Surg. 31 375 382 17171488 10.1007/s00268-006-0425-6 (Pubitemid 46183526)
30. M Shoup MF Brennan K McWhite DH Leung D Klimstra KC Conlon 2002 The value of splenic preservation with distal pancreatectomy Arch Surg. 137 164 168 11822953 10.1001/archsurg.137.2.164 (Pubitemid 34142132)
31. CD Robinette JF Fraumeni Jr 1977 Splenectomy and subsequent mortality in veterans of the 1939-45 war Lancet. 2 127 129 69206 10.1016/S0140-6736(77)90132- 5 1:STN:280:DyaE2s3htFGluw%3D%3D (Pubitemid 8124956)
32. TF Smith RB Johnston Jr 1979 Functions of the spleen in host defense against infection Am J Pediatr Hematol Oncol. 1 355 362 397780 1:STN:280:DyaL3c7ps1agtw%3D%3D (Pubitemid 11129771)
33. FK Swirski M Nahrendorf M Etzrodt, et al. 2009 Identification of splenic reservoir monocytes and their deployment to inflammatory sites Science. 325 612 616 19644120 10.1126/science.1175202 1:CAS:528:DC%2BD1MXptFOjtrk%3D
34. WP McGuire WJ Hoskins MF Brady, et al. 1996 Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med. 334 1 6 7494563 10.1056/ NEJM199601043340101 1:CAS:528:DyaK28XhtFKiur4%3D (Pubitemid 26012496)
35. FM Muggia PS Braly MF Brady, et al. 2000 Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study J Clin Oncol. 18 106 115 10623700 1:CAS:528:DC%2BD3cXmtFSrtQ%3D%3D (Pubitemid 30036343)
36. Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P. Interval debulking surgery for advanced epithelial ovarian cancer. Cochrane Database Syst Rev. 2009;(10):CD006014.